Pirfenidone suppresses keloid ?broblast-embedded collagen gel contraction

Archives of Dermatological Research

Volumn 304, Issue 3, 2012, Pages 217-222

  Saito, Masuyoshi ^a   Maeda, Tatsuo ^a   Setoguchi, Yasuhiro ^a   Yamazaki, Masashi ^a   Matsumura, Hajime ^a   Tsuboi, Ryoji ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen gel contraction; Fibroblasts; Keloid; Pirfenidone

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN GEL; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; CONNECTIVE TISSUE GROWTH FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PIRFENIDONE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; KELOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND CONTRACTION; WOUND HEALING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROBLASTS; GELS; HUMANS; KELOID; MALE; PYRIDONES; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84862851033     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1184-2     Document Type: Article

References (33)

1. Abergel RP, Pizzurro D, Meeker CA et al (1985) Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 84:384-390
2. Appleton I, Tomlinson A, Chander CL, Willoughby DA (1992) Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. Lab Invest 67:703-709
3. Armendariz-Borunda J, Lyra-Gonzalez I, Medina-Preciado D et al (2011) A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients. Ann Plast Surg doi: 10.1097/SAP.0b013e31821 b6d08
4. Azuma A, Nukiwa T, Tsuboi E et al (2005) Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171:1040-1047
5. Bell E, Ivarsson B, Merril C (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274-1278
6. Blom IE, Goldschmeding R, Leask A (2002) Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol 21:473-482
7. Clark RA (1985) Cutaneous tissue repair: biologic considerations. J Am Acad Dermatol 13:701-725
8. Cunningham JL, Tsolakis AV, Jacobson A, Janson ET (2010) Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin. Eur J Endocrinol 163:691-697
9. Di Sario A, Bendia E, Macarri G et al (2004) The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. Dig Liver Dis 36:744-751
10. Ehrlich HP (1988) Wound closure: evidence of cooperation between fibroblast and collagen matrix. Eye 2:149-157
11. Guidry C, Grinnell F (1985) Studies on the mechanism of hydrated collagen gel reorganization by human skin fibroblasts. J Cell Sci 79:67-81
12. Gupta S, Sharma VK (2011) Standard guidelines of care: Keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 77:94-100
13. Gurujeyalakshmi G, Hollinger MA, Giri SN (1999) Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol 276:L311-L318
14. Hasegawa T, Nakao A, Sumiyoshi K et al (2003) IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts. J Dermatol Sci 32:19-24
15. Hewitson TD, Kelynack KJ, Tait MG et al (2001) Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis. J Nephrol 14:453-460
16. Iyer SN, Gurujeyalakshmi G, Giri SN (1999) Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 291:367-373
17. Kakugawa T, Mukae H, Hayashi T et al (2004) Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. Eur Respir J 24:57-65
18. Lee YR, Oshita Y, Tsuboi R, Ogawa H (1996) Combination of insulin-like growth factor (IGF)-I and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. Endocrinology 137:5278-5283
19. Lin X, Yu M, Wu K et al (2009) Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Invest Ophthalmol Vis Sci 50:3763-3770
20. Murray JC, Pollack SV, Pinnell SR (1981) Keloids: a review. J Am Acad Dermatol 4:461-470
21. Nakagawa S, Pawelek P, Grinnell F (1989) Extracellular matrix organization modulates fibroblast growth and growth factor responsiveness. Exp Cell Res 182:572-582
22. Nakayama S, Mukae H, Sakamoto N et al (2008) Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts. Life Sci 82:210-217
23. Nakazato H, Oku H, Yamane S et al (2002) A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. Eur J Pharmacol 446:177-185
24. Nie Z, Bayat A, Behzad F, Rhodes LE (2010) Positive response of a recurrent keloid scar to topical methyl aminolevulinatephotodynamic therapy. Photodermatol Photoimmunol Photomed 26:330-332
25. Noble PW, Albera C, Bradford WZ, CAPACITY Study Group et al (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:1760-1769
26. Oshita Y, Lee YR, Ogawa H et al (2006) Endothelin-1 secreted from keratinocytes stimulates fibroblast-embedded collagen gel contraction in vitro. J Dermatol Sci 43:57-59
27. Raghu G, Johnson WC, Lockhart D, Mageto Y (1999) Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 159:1061-1069
28. Sharma K, Ix JH, Mathew AV et al (2011) Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22:1144-1151
29. Shetlar MR, Shetlar DJ, Bloom RF et al (1998) Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone. J Lab Clin Med 132:491-496
30. Sobral LM, Montan PF, Zecchin KG et al (2011) Smad7 blocks transforming growth factor-b1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor. J Periodontol 82:642-651
31. Suhr KB, Tsuboi R, Ogawa H (2000) Sphingosylphosphorylcholine stimulates contraction of fibroblast-embedded collagen gel. Br J Dermatol 143:66-71
32. Sumiyoshi K, Nakao A, Setoguchi Y et al (2003) Smads regulate collagen gel contraction by human dermal fibroblasts. Br J Dermatol 149:464-470
33. Zhang GY, Cheng T, Luan Q et al (2011) Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol 164:729-737